Mark Horvath's most recent trade in Hologic, Inc. was a trade of 113 Common Stock done at an average price of $75.2 . Disclosure was reported to the exchange on Feb. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Mark Horvath | President, Breast & Skeletal | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.15 per share. | 10 Feb 2026 | 113 | 23,026 (0%) | 0% | 75.2 | 8,492 | Common Stock |
| Hologic | Mark Horvath | President, Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2025 | 13,458 | 23,139 (0%) | 0% | - | Common Stock | |
| Hologic | Mark Horvath | President, Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 2,278 | 9,681 (0%) | 0% | - | Common Stock | |
| Hologic | Mark Horvath | Div. Pres., Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,844 | 2,844 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Mark Horvath | Div. Pres., Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 958 | 7,057 (0%) | 0% | - | Common Stock |